Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAPN1 | P07384 | 2/20 | 0.57 |
| ▸ | CTSB | P07858 | 2/20 | 0.57 |
| ▸ | CXCR4 | P61073 | 5/20 | 0.55 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.53 |
| ▸ | NPY1R | P25929 | 1/20 | 0.52 |
| ▸ | NPY2R | P49146 | 1/20 | 0.52 |
| ▸ | NPY4R | P50391 | 1/20 | 0.52 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.52 |
| ▸ | DPP3 | Q9NY33 | 2/20 | 0.51 |
| ▸ | CTNNB1 | P35222 | 3/20 | 0.51 |
| ▸ | F13A1 | P00488 | 2/20 | 0.51 |
| ▸ | TGM2 | P21980 | 2/20 | 0.51 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.50 |
| ▸ | TACR2 | P21452 | 1/20 | 0.49 |
| ▸ | GLP1R | P43220 | 1/20 | 0.49 |
| ▸ | GCGR | P47871 | 1/20 | 0.49 |
| ▸ | GIPR | P48546 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30343341 | 0.88 | DPP3 (0.55) | CAPN1CTSBCXCR4C5AR1NPY1R | |
| SCHEMBL31208374 | 0.87 | C5AR1 (0.58) | CAPN1CTSBCXCR4C5AR1CTNNB1 | |
| SCHEMBL30735734 | 0.87 | CXCR4 (0.58) | CAPN1CTSBCXCR4DPP3F13A1 | |
| SCHEMBL29463717 | 0.86 | CAPN1 (0.63) | CAPN1CTSBCXCR4C5AR1NPY1R | |
| SCHEMBL30498685 | 0.85 | CXCR4 (0.63) | CAPN1CTSBCXCR4C5AR1KISS1R | |
| SCHEMBL31158220 | 0.85 | CXCR4 (0.68) | CAPN1CTSBCXCR4C5AR1NPY1R | |
| SCHEMBL30343340 | 0.84 | C5AR1 (0.60) | CXCR4C5AR1CTNNB1F13A1TGM2 | |
| SCHEMBL30361030 | 0.84 | F13A1 (0.56) | CAPN1CTSBCXCR4C5AR1DPP3 | |
| SCHEMBL30565410 | 0.84 | C5AR1 (0.56) | CAPN1CTSBCXCR4C5AR1DPP3 | |
| SCHEMBL31235874 | 0.84 | CXCR4 (0.58) | CXCR4NPY1RNPY2RNPY4RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115279420-B | Polyol-based polypolyxylitol gene transporter containing cancer stem cell specific binding peptide and binding to vitamin B6 | 埃尔比奥股份有限公司 | 2024-05-28 | — | — | CN | disclosed |
| US-20230098307-A1 | VITAMIN B6-COUPLED POLYOL-BASED POLYDIXYLITOL GENE TRANSPORTER COMPRISING PEPTIDE BINDING SPECIFICALLY TO CANCER STEM CELL AND CANCER STEM CELL-TARGETED THERAPY TECHNIQUE | ELBIO INC (KR) | 2023-03-30 | — | — | US | disclosed |
| CN-115279420-A | Polyol-based polydixylitol gene transporter containing cancer stem cell specific binding peptide and binding with vitamin B6, and cancer stem cell targeted therapy technology | 埃尔比奥股份有限公司 | 2022-11-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230098307-A1 | VITAMIN B6-COUPLED POLYOL-BASED POLYDIXYLITOL GENE TRANSPORTER COMPRISING PEPTIDE BINDING SPECIFICALLY TO CANCER STEM CELL AND CANCER STEM CELL-TARGETED THERAPY TECHNIQUE | SLC19A2, SLC19A1, SLC46A1 | CAPN1 4819/4885CTSB 4127/4885CXCR4 666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.